Skip to main content
logo
UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
43.62
-1.88 (-4.13%)
At close: Aug 28, 2026, 4:00 PM EDT
44.98
+1.36 (3.12%)
After-hours: Aug 28, 2026, 7:59 PM EDT

UroGen Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,1321,096449463205213
Market Cap Growth
135.86%143.93%-2.93%126.06%-3.94%-46.44%
Enterprise Value
2,2201,099318409184105
Last Close Price
43.6223.4210.6515.008.879.51

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.309.994.975.603.184.44
PB Ratio
--10.39-51.05-7.10-2.2925.34
P/TBV Ratio
-----25.34

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
11.7610.013.524.952.852.18

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.48-1.23-14.19-1.54-1.120.18
Net Debt / Equity Ratio
-0.67-0.0913.270.630.00-10.50
Net Debt / EBITDA Ratio
-1.33-0.081.230.640.000.97
Net Debt / FCF Ratio
-0.55-0.061.200.540.001.03
Asset Turnover
0.820.450.390.530.500.40
Inventory Turnover
1.090.971.191.871.671.52
Quick Ratio
3.183.315.594.884.714.51
Current Ratio
3.804.016.015.425.395.11
Return on Equity (ROE)
------211.55%
Return on Assets (ROA)
-18.06%-32.10%-25.77%-26.10%-38.69%-47.72%
Return on Capital Employed (ROCE)
-35.00%-81.10%-39.90%-44.60%-70.80%-94.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.58%-14.00%-28.23%-22.08%-53.60%-51.98%
FCF Yield
-7.46%-14.84%-21.60%-16.54%-42.88%-40.17%
Buyback Yield / Dilution
-4.63%-12.22%-48.70%-26.43%-2.05%-2.60%
SEC Filings: 10-K · 10-Q